Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease
Background: Fibrates have renal toxicity limiting their use in subjects with chronic kidney disease (CKD). However, pemafibrate has fewer toxic effects on renal function. In the present analysis, we evaluated the effects of pemafibrate on the renal function of diabetic subjects with or without CKD i...
Saved in:
Published in | Diabetes & metabolism journal Vol. 48; no. 3; pp. 473 - 489 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | Korean |
Published |
대한당뇨병학회
2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!